Predicting CTLA4 expression and prognosis in clear cell renal cell carcinoma using a pathomics signature of histopathological images and machine learning
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82372724)
This publication has 42 references indexed in Scilit:
- Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell CarcinomaEuropean Urology, 2023
- Computed tomography‐based radiomics prediction of CTLA4 expression and prognosis in clear cell renal cell carcinomaCancer Medicine, 2022
- Epidemiology of Renal Cell Carcinoma: 2022 UpdateEuropean Urology, 2022
- Immune checkpoint inhibitor-based therapy for advanced clear cell renal cell carcinoma: A narrative reviewInternational Immunopharmacology, 2022
- Classification of acute myeloid leukemia M1 and M2 subtypes using machine learningComputers in Biology and Medicine, 2022
- Integration of histopathological images and multi-dimensional omics analyses predicts molecular features and prognosis in high-grade serous ovarian cancerGynecologic Oncology, 2021
- Histopathological image and gene expression pattern analysis for predicting molecular features and prognosis of head and neck squamous cell carcinomaCancer Medicine, 2021
- Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trialThe Lancet Oncology, 2019
- Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysisGynecologic Oncology, 2017
- Association of functional genetic variants of CTLA4 with reduced serum CTLA4 protein levels and increased risk of idiopathic recurrent miscarriagesFertility and Sterility, 2016